Dried Blood Spots as a Clinical Samples for Laboratory Diagnosis and Surveillance of Vaccine-Preventable Diseases in Bulgaria
AbstractIn recent years the dried blood spots (DBS) had new and innovative applications in medicine, neonatology, virology and microbiology. This study aimed to evaluation of the frequency of detection of viral IgM/IgG markers in dried blood spots and introducing an easy-to-implement protocol for serum extraction in measles, mumps and rubella surveillance. The total 204 clinical samples (102 serum samples and 102 dried blood spots) collected from 102 patients were included. All specimens were tested for presence of specific viral markers (IgM and IgG antibodies) by a commercial indirect enzyme-linked immunosorbent assay (ELISA). Of all tested patients, three (3/102, 2.94%, 95% CI: 0 ÷ 6.22) were confirmed for acute measles infection and two (2/102, 1.96%, 95% CI: 0 ÷ 4.65) for mumps. Double positive ELISA-IgM results were found in their serum samples and DBS. No acute rubella infection and rubella IgM marker were detected in both clinical samples. By immunoassay analysis of all 102 patients, measles, mumps and rubella IgG were found in 83/102 (81%, 95% CI: 73.40 ÷ 88.60), 76/102 (75%, 95% CI: 66.60 ÷ 83.40) and 79/102 (77%, 95% CI: 68.83 ÷ 85.17) serum samples. Comparative results were obtained in the adequately obtained DBS. Viral IgG seroprevalence in DBS were obtained in 79/102 (77%, 95% CI: 68.83 ÷ 85.17) for measles, 69/102 (68%, 95% CI: 58.67 ÷ 77.33) for mumps and 73/102 (72%, 95% CI: 63 ÷ 81) for rubella, respectively. Double negative results for each screened viral markers were proven in six tested patients.The study shown higher extinction value (Ratio and NovaTec units) in DBS compared to serum samples of same persons were calculated. Our studies show over 90% coincidence in combined ELISA assay of viral markers against measles, mumps, and rubella in serum samples and DBS. DBS clinical approach is non-aggressive and more acceptable to the public (including young children, pregnant women, etc.). It has a variety of new and innovative applications in medicine and in particular in the laboratory diagnosis of acute and past (presence of protective immunity) measles, mumps and rubella infection in the phase of elimination.
WHO. (2008). Measles and rubella laboratory network: 2007 meeting on use of alternative sampling techniques for surveillance. Weekly Epidemiological Record, vol. 83, pp. 229-232. http://www.who.int/wer/2008/wer8325.pdf?ua=1
De Swart R., Nur Y., Abdallah A., et. al. (2001). Combination of reverse transcriptase PCR analysis and immunoglobulin M detection on filter paper blood samples allows diagnostic and epidemiological studies of measles. J. Clin Microbiol, vol. 39, pp. 270-273.
Barfield M., Spooner N., Lad R., et. al. Barfield, M., et al. (2008). Application of Dried Blood Spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies, J Chromatograph B., vol. 870, pp. 32-7.
Rosalia L., Maldonado-Rodriguez A., Rojas-Montes O. et. al. (2009). Use of dried blood samples for monitoring hepatitis B virus Infection. Virology Journal, vol. 6, pp. 153.
Waterboer T., Dondog B., Michael K. et. al. (2012). Dried Blood Spot Samples for Seroepidemiology of Infections with Human Papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus. Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 287-293.
Johannessen A. (2010). Dried blood spots in HIV monitoring: applications in resource-limited settings. Bioanalysis. vol 2, pp. 1893-908.
Lim M. (2018). Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges.Am J Trop Med Hyg. vol. 99, pp. 256–265.
Marques B., Brandão C., Silva E., et al. (2012). Dried blood spot samples: optimization of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions. J Med Virol. vol. 84, pp. 1600-1607.
Larrat, S., Bourdon C., Baccard M. et al. (2012). Performance of an antigen–antibody combined assay for hepatitis C virus testing without venipuncture. J Clin Virol. vol. 55, pp. 220-225.
Blood Collection on Filter Paper for Newborn Screening Programs (2013); Approved Standard-Sixth Edition. Clinical and Laboratory Standards Institute (CLSI) Wayne, PA http://shop.clsi.org/c.1253739/site/Sample_pdf/NBS01A6_sample.pdf.
Helfand, R.F., et al. (2001). Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol., vol. 65, pp. 751-757.
Karapanagiotidis T., Riddell M., Kelly H. (2005). Detection of rubella immunoglobulin M from dried venous blood spots using a commercial enzyme immunoassay. Diagn Microbiol Infect Dis., vol. 53, pp. 107-111.
Uzicanin A., Lubega I., Nanuynja M., et. al. (2011). Dried Blood Spots on Filter Paper as an Alternative Specimen for Measles Diagnostics: Detection of Measles Immunoglobulin M Antibody by a Commercial Enzyme Immunoassay. The J of Infec Dis, vol. 204, pp. 564-569.
Helfand R., Cabezas C., Abernathy E. et. al. (2007). Dried Blood Spots versus Sera for Detection of Rubella Virus-Specific Immunoglobulin M (IgM) and IgG in Samples Collected during a Rubella Outbreak in Peru. Clinical and Vaccine Immunology, vol. 14, pp. 1522–1525.
Riddell M., Leydon J., Catton M., et al. (2002). Detection of measles virus-specific immunoglobulin M in dried venous blood samples by using a commercial enzyme assay. J. Clin Microbiol, vol. 40, pp. 5-9.
Authors who submit papers with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
- It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper. The Editor In Chief will choose any option from the following to review the submitted papers:A. send the paper to two reviewers, if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he take immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor have the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he have the right to accept\reject the paper.B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
- Author will take the responsibility what so ever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
- Before publishing, author must check whether this journal is accepted by his employer, or any authority he intends to submit his research work. we will not be responsible in this matter.
- If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.
- The cost covered in the publication fees is only for online publication of a single manuscript.